Early Stage Clinical Trial of Ginger (Zingiber officinale) as an Add-on Antiepileptic Therapy in Children with Generalized Epilepsies

Authors

  • Abdel Moneim A Eisa Department of Pharmacology, Faculty of Pharmacy, University of Gezira
  • Hayder E Babiker Department of paediatrics, Faculty of Medicine, University of Gezira
  • Imad Eldin M Taj Eldin Department of Pharmacology, Faculty of Pharmacy, University of Gezira
  • Enas M El Tahir Department of pharmaceutical chemistry, Faculty of Pharmacy, University of Gezira
  • Elhadi M Mohamed Ahmed Department of pharmacognosy, Faculty of Pharmacy, University of Gazira

DOI:

https://doi.org/10.53332/kjps.v1i1.38

Keywords:

Ginger, Epilepsy, Add-on antiepileptic, Clinical trials

Abstract

Epilepsy is a disorder of the brain characterized by the generation of epileptic seizures. Botanicals and herbal materials including some parts from plants are prepared and taken in many ways for treatment of children ill with epilepsy. Conventional

Downloads

Published

2021-08-11

How to Cite

Eisa, A. M. A. ., Babiker, H. E. ., Taj Eldin, I. E. M. ., El Tahir, E. M., & Ahmed, . E. M. M. . (2021). Early Stage Clinical Trial of Ginger (Zingiber officinale) as an Add-on Antiepileptic Therapy in Children with Generalized Epilepsies. Khartoum Journal of Pharmaceutical Sciences, 1(1). https://doi.org/10.53332/kjps.v1i1.38

Issue

Vol. 1 No. 1 (2020): khartoum Journal of Pharmaceutical Sciences

Section

Articles